The National Optometric Association: Looking back to move forward

Published on August 14, 2025
Sherrol A. Reynolds, OD, FAAO, details how NOA's history impacts its vision for the future.
Continue reading on website
Other news

Opus Genetics Announces Financial Results for Second Quarter 2025 and Provides Product Pipeline Updates

August 14, 2025
RESEARCH TRIANGLE PARK, N.C.—Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and small molecule therapies for other ophthalmic disorders, yesterday announced financial results for the second quarter ended June 30, 2025, and provided a corporate update. Net loss for the second quarter of 2

Study Highlights Retinal Thickness Changes Linked to Glaucoma Severity

August 14, 2025
Structural changes in the retina and optic nerve head, visualized using OCT, typically precede functional loss in glaucoma. Thinning of the circumpapillary retinal nerve fiber layer (cpRNFL), for example, is an early indicator of glaucomatous damage, and macular ganglion cell-inner plexiform layer (mGCIPL) thickness is another likely candidate for tracking progression. Uncovering the rates of thin